Literature DB >> 18227265

Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.

C K Cote1, J Bozue, K L Moody, T L DiMezzo, C E Chapman, S L Welkos.   

Abstract

The significance of Bacillus anthracis as an agent of bioterrorism has been well established. An understanding of both the pathogenesis and the host response is required to elucidate approaches to more rapidly detect and effectively prevent or treat anthrax. Current vaccine strategies are focused primarily on production of antibodies against the protective antigen components of the anthrax toxins, which are secreted by the bacilli. A better understanding of the dynamic morphology of the dormant and germinating spore and its interaction with the host immune system could be important in developing an optimally efficacious anthrax vaccine. A spore-associated protein was identified that was specific to the Bacillus cereus group of bacteria and referred to as spore opsonization-associated antigen A (SoaA). Immuno-electron microscopy localized this protein to the area of the cortex beneath the coat of the dormant spore. Although our data suggested that SoaA was found below the coat layers of the ungerminated spore, SoaA was involved in the interaction of spores with macrophages shortly after infection. To investigate further the specific properties of the SoaA protein, the soaA gene was inactivated in the B. anthracis Ames strain. The SoaA protein in the Ames strain of B. anthracis increased the phagocytic uptake of the spores in the presence of anti-spore antibodies. Unlike the wild-type strain, the mutant soaA : : Kan strain was not readily opsonized by anti-spore antibodies. While the mutant spores retained characteristic resistance properties in vitro and virulence in vivo, the soaA : : Kan mutant strain was significantly less suited for survival in vivo when competed against the wild-type Ames strain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227265     DOI: 10.1099/mic.0.2007/008292-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  12 in total

1.  Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence.

Authors:  Amy Jenkins; Christopher Cote; Nancy Twenhafel; Tod Merkel; Joel Bozue; Susan Welkos
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 2.  The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host.

Authors:  George C Stewart
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

3.  Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.

Authors:  C K Cote; L Kaatz; J Reinhardt; J Bozue; S A Tobery; A D Bassett; P Sanz; S C Darnell; F Alem; A D O'Brien; S L Welkos
Journal:  J Med Microbiol       Date:  2012-07-05       Impact factor: 2.472

4.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

5.  Roles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination.

Authors:  Kari M Severson; Michael Mallozzi; Joel Bozue; Susan L Welkos; Christopher K Cote; Katherine L Knight; Adam Driks
Journal:  J Bacteriol       Date:  2009-10-16       Impact factor: 3.490

6.  Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains.

Authors:  Sanghamitra Mukhopadhyay; Arya Akmal; Andrew C Stewart; Ru-Ching Hsia; Timothy D Read
Journal:  Mol Cell Proteomics       Date:  2009-02-09       Impact factor: 5.911

7.  Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Authors:  Tanya M Jelacic; Donald J Chabot; Joel A Bozue; Steven A Tobery; Michael W West; Krishna Moody; De Yang; Joost J Oppenheim; Arthur M Friedlander
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

8.  Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.

Authors:  Kanchan Sinha; Rakesh Bhatnagar
Journal:  Med Microbiol Immunol       Date:  2012-12-21       Impact factor: 3.402

9.  Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.

Authors:  Robert J Cybulski; Patrick Sanz; Dennis McDaniel; Steve Darnell; Robert L Bull; Alison D O'Brien
Journal:  Vaccine       Date:  2008-07-25       Impact factor: 3.641

Review 10.  Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.

Authors:  Christopher K Cote; Susan L Welkos
Journal:  Toxins (Basel)       Date:  2015-08-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.